NanoGroup S.A.

Equities

NNG

PLNNGRP00011

Biotechnology & Medical Research

Market Closed - Warsaw S.E. Other stock markets 11:55:50 2024-05-14 am EDT			5-day change	1st Jan Change
1.03 ^PLN	+0.98%		+0.49%	+10.99%

2023	NanoGroup S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023	CI
2023	NanoGroup S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	CI

Nanogroup S.A. Reports Earnings Results for the First Quarter Ended March 31, 2021

May 28, 2021 at 12:18 pm EDT

NanoGroup S.A. Announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was PLN 4,822 compared to PLN 1,500 a year ago. Operating income was PLN 21 compared to PLN 7,139 a year ago. Net loss was PLN 1.082 million compared to PLN 431,142 a year ago.

Latest news about NanoGroup S.A.

NanoGroup S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023	Nov. 06	CI
NanoGroup S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-29	CI
NanoGroup S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-19	CI
NanoGroup S.A. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-11-29	CI
NanoGroup S.A. Reports Earnings Results for the Half Year Ended June 30, 2022	22-09-19	CI
NanoGroup S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-27	CI
NanoGroup S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-29	CI
NanoGroup S.A. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-11-26	CI
Nanogroup S.A. Reports Earnings Results for the Half Year Ended June 30, 2021	21-10-04	CI
Nanogroup S.A. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-28	CI
An undisclosed buyer acquired 35.24% stake in NanoGroup S.A. from GPV I Inwestycje Sp. z o.o.	18-07-18	CI
NanoGroup S.A. has completed an IPO in the amount of PLN 4.18 million.	17-11-21	CI
NanoGroup Seeks Acquisitions	17-10-25	CI
NanoGroup Seeks Acquisition	17-10-20	CI
NanoGroup Seeks Acquisitions	17-10-17	CI
NanoGroup S.A. has filed an IPO in the amount of PLN 45 million.	17-10-13	CI

Chart NanoGroup S.A.

Duration

Period

More charts

Company Profile

Nanogroup SA is a Poland-based company engaged in the biotechnology sector. The Company focuses on the investment in, as well as development of advanced biotechnological projects in the areas of cancer prevention, early diagnosis, targeted cancer therapies and ontological rehabilitation. Its projects portfolio includes NanoVelos, which is responsible for the creation of drug delivery system for proven oncologic medicines to optimize their performance; NanoSanguis, which develops artificial blood to keep alive patients wounded in accidents, as well as a system, named Organ farm, to preserve human organs ex vivo, and NanoThea, which is dedicated to technology that detects cancer cells in early stage.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
NANOGROUP S.A.	+10.99%	5.16M
MODERNA, INC.	+29.03%	48.16B
IQVIA HOLDINGS INC.	-0.10%	41.73B
LONZA GROUP AG	+43.45%	41.03B
CELLTRION, INC.	-5.26%	28.77B
ICON PUBLIC LIMITED COMPANY	+11.48%	25.59B
ALNYLAM PHARMACEUTICALS, INC.	-22.74%	18.96B
BIO-TECHNE CORPORATION	+9.06%	12.92B
MEDPACE HOLDINGS, INC.	+30.01%	12.03B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.51%	11.77B

Other Biotechnology & Medical Research